These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 11434771)

  • 1. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
    Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
    Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
    Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY
    Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.
    Xu W; Campillo M; Pardo L; Kim de Riel J; Liu-Chen LY
    Biochemistry; 2005 Dec; 44(49):16014-25. PubMed ID: 16331961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the mu opioid receptor involves conformational rearrangements of multiple transmembrane domains.
    Xu W; Sanz A; Pardo L; Liu-Chen LY
    Biochemistry; 2008 Oct; 47(40):10576-86. PubMed ID: 18778083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The local environment at the cytoplasmic end of TM6 of the mu opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates the mu opioid receptor and reduces the constitutive activity of its T6.34(279)K mutant.
    Huang P; Visiers I; Weinstein H; Liu-Chen LY
    Biochemistry; 2002 Oct; 41(40):11972-80. PubMed ID: 12356297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor.
    Nebane NM; Hurst DP; Carrasquer CA; Qiao Z; Reggio PH; Song ZH
    Biochemistry; 2008 Dec; 47(52):13811-21. PubMed ID: 19053233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
    Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
    J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.
    Javitch JA; Ballesteros JA; Chen J; Chiappa V; Simpson MM
    Biochemistry; 1999 Jun; 38(25):7961-8. PubMed ID: 10387039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp.
    Huang P; Li J; Chen C; Visiers I; Weinstein H; Liu-Chen LY
    Biochemistry; 2001 Nov; 40(45):13501-9. PubMed ID: 11695897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.
    Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG
    Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.
    Javitch JA; Shi L; Simpson MM; Chen J; Chiappa V; Visiers I; Weinstein H; Ballesteros JA
    Biochemistry; 2000 Oct; 39(40):12190-9. PubMed ID: 11015197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents.
    Deng HB; Guang W; Wang JB
    J Pharmacol Exp Ther; 2000 Apr; 293(1):113-20. PubMed ID: 10734160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice.
    Javitch JA; Ballesteros JA; Weinstein H; Chen J
    Biochemistry; 1998 Jan; 37(4):998-1006. PubMed ID: 9454590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of phospholipase C by the cloned mu, delta and kappa opioid receptors via chimeric G alpha(q) mutants.
    Joshi S; Lee JW; Wong YH
    Eur J Neurosci; 1999 Feb; 11(2):383-8. PubMed ID: 10051738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endomorphin-1 discriminates the mu-opioid receptor from the delta- and kappa-opioid receptors by recognizing the difference in multiple regions.
    Ide S; Sakano K; Seki T; Awamura S; Minami M; Satoh M
    Jpn J Pharmacol; 2000 Aug; 83(4):306-11. PubMed ID: 11001176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine 2.59(89) in the second transmembrane domain of human CB2 receptor is accessible within the ligand binding crevice: evidence for possible CB2 deviation from a rhodopsin template.
    Zhang R; Hurst DP; Barnett-Norris J; Reggio PH; Song ZH
    Mol Pharmacol; 2005 Jul; 68(1):69-83. PubMed ID: 15840841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
    Wang WW; Shahrestanifar M; Jin J; Howells RD
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle.
    Shi L; Simpson MM; Ballesteros JA; Javitch JA
    Biochemistry; 2001 Oct; 40(41):12339-48. PubMed ID: 11591153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor.
    Zhu J; Xue JC; Law PY; Claude PA; Luo LY; Yin J; Chen C; Liu-Chen LY
    FEBS Lett; 1996 Apr; 384(2):198-202. PubMed ID: 8612823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.